Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
Interventions: DRUG: Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
Sponsor: International Cancer Research Group, United Arab Emirates
Collaborators: King Saud University Medical City, Riyadh, Saudi Arabia|Max-Planck-Institut für Quantenoptik (MPQ), and Faculty of Physics at Ludwig-Maximilians-Universität München (LMU), Garching, Germany|King Abdallah University for Science and Technology (KAUST), Thuwal, Saudi Arabia.